Cetera Investment Advisers decreased its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 36.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,795 shares of the company's stock after selling 31,508 shares during the period. Cetera Investment Advisers owned approximately 0.13% of Vital Farms worth $2,103,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. CIBC Private Wealth Group LLC lifted its stake in Vital Farms by 152.1% during the 4th quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock valued at $35,000 after acquiring an additional 540 shares during the period. US Bancorp DE lifted its stake in Vital Farms by 160.3% during the 4th quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after acquiring an additional 872 shares during the period. Frazier Financial Advisors LLC bought a new position in Vital Farms during the 4th quarter valued at about $59,000. Principal Securities Inc. lifted its stake in Vital Farms by 29.4% during the 4th quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock valued at $63,000 after acquiring an additional 380 shares during the period. Finally, Rothschild Investment LLC lifted its stake in Vital Farms by 191.2% during the 4th quarter. Rothschild Investment LLC now owns 1,814 shares of the company's stock valued at $68,000 after acquiring an additional 1,191 shares during the period. Institutional investors own 98.59% of the company's stock.
Vital Farms Price Performance
Shares of NASDAQ:VITL opened at $35.80 on Monday. The firm's 50 day moving average price is $32.79 and its 200-day moving average price is $35.02. Vital Farms, Inc. has a twelve month low of $27.91 and a twelve month high of $48.41. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.59 billion, a PE ratio of 31.96 and a beta of 0.94.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.11. The company had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The firm's quarterly revenue was up 9.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.43 EPS. Equities research analysts expect that Vital Farms, Inc. will post 1.11 EPS for the current year.
Insider Buying and Selling
In other Vital Farms news, CEO Russell Diez-Canseco sold 45,124 shares of the stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the completion of the sale, the chief executive officer now directly owns 703,736 shares of the company's stock, valued at $23,708,865.84. This trade represents a 6.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Matthew Ohayer sold 24,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $32.68, for a total transaction of $784,320.00. Following the sale, the insider now directly owns 6,942,890 shares of the company's stock, valued at approximately $226,893,645.20. This trade represents a 0.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 93,124 shares of company stock valued at $3,019,308. 27.60% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on VITL. Morgan Stanley lowered their target price on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. BMO Capital Markets upgraded shares of Vital Farms to a "strong-buy" rating in a research note on Tuesday, May 6th. William Blair restated an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Telsey Advisory Group reiterated an "outperform" rating and issued a $52.00 price objective on shares of Vital Farms in a research note on Monday, May 5th. Finally, Stifel Nicolaus upgraded shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective on the stock in a research note on Friday, February 28th. Eight analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $44.63.
Check Out Our Latest Stock Report on VITL
Vital Farms Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Articles
Want to see what other hedge funds are holding VITL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vital Farms, Inc. (NASDAQ:VITL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.